ARTICLE | Company News
Origen Therapeutics Inc. other research news
July 24, 2000 7:00 AM UTC
Origen received a $100,000 Phase I SBIR grant from National Institute of Child Health and Human Development to establish ES cell cultures from early-stage chicken embryos. The company said that the us...